Why We Invested In Banjo Health – Simplifying Medical Paperwork Through AI

2 min read

  Excited to announce our investment alongside Epsilon Health Investors in the $5M series A in Banjo Health which employs artificial intelligence in prior authorization (PA) i.e., reduces medical paperwork. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in mature seed, typically when there is a pipeline of customers, but we occasionally take earlier or later bets when we see immense promise. Banjo falls on that latter exception, having been founded in 2019, raising a pre-seed with strong angels, and skipping the seed altogether. They impressed us with (1) addressing a strong need, (2) building an execution-focused…...

This article is free to read

Login to read the full article


OR

By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Amit Garg I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.